Recent

% | $
Quotes you view appear here for quick access.

Cytokinetics, Incorporated Message Board

  • nidan7500 nidan7500 Apr 23, 2013 9:33 AM Flag

    curiouser and curiouser

    Why would an issue with pending-possible RS be up in volume and price? Could it be that speculation on good news is driving vs speculation on screwing the sharholders? Cards anyone?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • What RS????? That's standard boilerplate with low price shares. They getthe board to approve a RS in case they need it. You haven't seen any sign of it have you?
      It's what they call a "shelf resolution."
      Get with the program. We're well above the need for any RS and we're well on our way to $2 prior to EOM.
      My guess is we're going to be heady with good news after the conference call.

      Sentiment: Strong Buy

    • I will throw in my quarter.

      1) I remember looking at limited models with similar RS announcements. Stock climbs post announcement and RS, then company issues a new offering and SP returns to current value. Process takes around 8 months. Time frame could change if CYTK does not do an offering, value may plateau at higher value, (best case). Others may find different models that show other results. Fundamentals look strong with CYTK, so motive of reducing stock to increase attractiveness to larger investors may carry weight as rationale.
      2) These horns could also be load up for future shorts as well, we will know when we see our first basher...
      3) Company is solid and investors are hyped , (that's my category).

      Sentiment: Strong Buy

 
CYTK
9.95-0.41(-3.96%)Jul 28 4:00 PMEDT